Lin M, Paik E, Mishra B, et al. Re-creating hereditary persistence of fetal hemoglobin (PHFH) with CRISPR/CAS9 to treat sickle cell disease (SCD) and beta-thalassemia (beta-thal). EHA 2017, abstract S147.
Emicizumab-profylaxe bij hemofilie-A met remmers: HAVEN 1
jul 2017 | Benigne hematologie